EA201591617A1 - Производные пиразолилбензо[d]имидазола - Google Patents

Производные пиразолилбензо[d]имидазола

Info

Publication number
EA201591617A1
EA201591617A1 EA201591617A EA201591617A EA201591617A1 EA 201591617 A1 EA201591617 A1 EA 201591617A1 EA 201591617 A EA201591617 A EA 201591617A EA 201591617 A EA201591617 A EA 201591617A EA 201591617 A1 EA201591617 A1 EA 201591617A1
Authority
EA
Eurasian Patent Office
Prior art keywords
absent
производные
пиразолилбензо
имидазола
nrr
Prior art date
Application number
EA201591617A
Other languages
English (en)
Other versions
EA026782B1 (ru
Inventor
Даря Здзалик
Йоанна Липнер
Мацей Вечорек
Каролина Дзвонек
Абделла Ямани
Кшиштоф Дубель
Моника Лямпарска-Пшибыш
Паулина Грыгелевич
Александра Станчак
Original Assignee
Целон Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Целон Фарма С.А. filed Critical Целон Фарма С.А.
Publication of EA201591617A1 publication Critical patent/EA201591617A1/ru
Publication of EA026782B1 publication Critical patent/EA026782B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Соединение, представленное общей формулой (I), где атомы водорода, показанные как присоединенные к пиразольному и бензимидазольному кольцам, присоединены к одному из атомов азота пиразольного или бензимидазольного кольца, соответственно; Rпредставляет собой -X-Q-P, где X отсутствует или представляет собой -СН-, -С(О)- или -C(O)NH-(CH)-, где k представляет собой 0, 1 или 2; Q выбран из группы, состоящей из Q1, Q2, Q3, Q4 и Q5; Р отсутствует или представляет собой С1-С3 алкил с прямой или разветвленной цепью, -(CH)-NRRили -(CH)-C(O)-NRR, где I и m независимо друг от друга представляют собой 0, 1 или 2, при условии, что когда В в Q1 представляет собой атом кислорода, то Р отсутствует; и Rи Rнезависимо друг от друга представляют собой С1 или С2 алкил, или Rи Rвместе с атомом азота, к которому они оба присоединены, образуют 6-членное насыщенное гетероциклическое кольцо, при этом один из атомов углерода в указанном гетероциклическом кольце может быть необязательно заменен на -О-, -NH- или -N(C1-C2) алкил; и его соли присоединения кислоты. Соединение может быть применено для лечения раковых заболеваний.
EA201591617A 2013-03-14 2014-03-07 ПРОИЗВОДНЫЕ ПИРАЗОЛИЛБЕНЗО[d]ИМИДАЗОЛА EA026782B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL403149A PL403149A1 (pl) 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu
PCT/IB2014/059515 WO2014141015A1 (en) 2013-03-14 2014-03-07 Pyrazolylbenzo[d]imidazole derivatives

Publications (2)

Publication Number Publication Date
EA201591617A1 true EA201591617A1 (ru) 2016-01-29
EA026782B1 EA026782B1 (ru) 2017-05-31

Family

ID=50382512

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591617A EA026782B1 (ru) 2013-03-14 2014-03-07 ПРОИЗВОДНЫЕ ПИРАЗОЛИЛБЕНЗО[d]ИМИДАЗОЛА

Country Status (20)

Country Link
US (1) US9776988B2 (ru)
EP (1) EP2970210B1 (ru)
JP (1) JP6594779B2 (ru)
KR (1) KR102266546B1 (ru)
CN (1) CN105008348B (ru)
AU (1) AU2014229401B2 (ru)
BR (1) BR112015023092B1 (ru)
CA (1) CA2900629C (ru)
DK (1) DK2970210T3 (ru)
EA (1) EA026782B1 (ru)
ES (1) ES2622376T3 (ru)
HR (1) HRP20170190T1 (ru)
HU (1) HUE031368T2 (ru)
IL (1) IL241234A0 (ru)
MX (1) MX364172B (ru)
PL (2) PL403149A1 (ru)
PT (1) PT2970210T (ru)
SI (1) SI2970210T1 (ru)
WO (1) WO2014141015A1 (ru)
ZA (1) ZA201507548B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3296297A1 (en) * 2016-09-15 2018-03-21 Centre National De La Recherche Scientifique Benzimidazol derivatives for treating filovirus infection
CN107698538B (zh) * 2016-11-30 2020-02-14 内蒙古京东药业有限公司 罗沙替丁醋酸酯盐酸盐的中间体3-(1-哌啶甲基)苯酚的制备方法
CN107163030B (zh) * 2017-06-20 2020-03-24 河南工业大学 具有吡唑母核的小分子杂环化合物及其用于制备抗菌、抗肿瘤药物的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU779686B2 (en) 1999-08-02 2005-02-03 Ortho-Mcneil Pharmaceutical, Inc. C-6 ring-substituted pyrido(1,2-a)benzimidazole derivatives useful in treating central nervous system disorders
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
US6897208B2 (en) 2001-10-26 2005-05-24 Aventis Pharmaceuticals Inc. Benzimidazoles
JP5063351B2 (ja) * 2004-09-17 2012-10-31 エグゼリクシス, インコーポレイテッド ピラゾールキナーゼモジュレーターおよび使用方法
JP5507049B2 (ja) 2004-12-30 2014-05-28 アステックス、セラピューティックス、リミテッド 医薬品
JP5474354B2 (ja) * 2005-12-30 2014-04-16 アステックス、セラピューティックス、リミテッド 医薬化合物
US7737149B2 (en) * 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
KR20110020904A (ko) * 2008-06-19 2011-03-03 아스트라제네카 아베 피라졸 화합물 436
UY33756A (es) * 2010-11-30 2012-06-29 Takeda Pharmaceutical Compuesto biciclico
ES2651143T3 (es) * 2011-05-13 2018-01-24 Glaxosmithkline Biologicals Sa Antígenos de F de prefusión del VRS

Also Published As

Publication number Publication date
HUE031368T2 (en) 2017-07-28
HRP20170190T1 (hr) 2017-04-07
ZA201507548B (en) 2017-02-22
CA2900629A1 (en) 2014-09-18
KR102266546B1 (ko) 2021-06-21
DK2970210T3 (en) 2017-04-10
US9776988B2 (en) 2017-10-03
WO2014141015A1 (en) 2014-09-18
CN105008348A (zh) 2015-10-28
BR112015023092A2 (pt) 2017-07-18
CN105008348B (zh) 2018-07-10
ES2622376T3 (es) 2017-07-06
AU2014229401B2 (en) 2018-05-17
PL2970210T3 (pl) 2017-09-29
AU2014229401A1 (en) 2015-08-20
EA026782B1 (ru) 2017-05-31
PT2970210T (pt) 2017-04-07
BR112015023092B1 (pt) 2021-11-16
US20160039794A1 (en) 2016-02-11
SI2970210T1 (sl) 2017-05-31
MX364172B (es) 2019-04-15
PL403149A1 (pl) 2014-09-15
JP6594779B2 (ja) 2019-10-23
KR20150126893A (ko) 2015-11-13
IL241234A0 (en) 2015-11-30
EP2970210A1 (en) 2016-01-20
EP2970210B1 (en) 2017-01-04
MX2015012346A (es) 2016-02-03
JP2016516024A (ja) 2016-06-02
CA2900629C (en) 2020-12-15

Similar Documents

Publication Publication Date Title
CY1125004T1 (el) Ετεροαρυλο υποκατεστημενες βητα-υδροξυαιθυλαμινες για χρηση στη θεραπεια της υπεργλυκαιμιας
UA115176C2 (uk) Інгібітори протеїнкінази
RS54010B1 (en) INHIBITOR PROLIL HYDROXYLASE
EA201100763A1 (ru) Методы получения хинолиновых производных
EA201490759A1 (ru) Ингибиторы протеинкиназы
UA114656C2 (uk) Похідні піридину
CL2012000311A1 (es) Compuestos derivados que contiene ciclos con 3 atomos de nitrogeno; utiles en el tratamiento de parasitosis en animales.
MX2015011534A (es) Nuevos derivados de pirazol.
TR201904327T4 (tr) Dimetilbenzoik asit bileşikleri.
TR201907373T4 (tr) Tetrazolinon bileşiği ve bunun kullanımı.
IN2014DN07509A (ru)
CY1119296T1 (el) Ενωση δικαρβοξυλικου οξεος
EA201690894A1 (ru) Феноксиэтилы
SG11201808171PA (en) Griseofulvin compound
EA201492255A1 (ru) Феноксиэтилпиперидиновые соединения
MX2015009774A (es) Composiciones catalizadoras novedosas y metodos para su elaboracion y uso.
EA201001087A1 (ru) Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201591617A1 (ru) Производные пиразолилбензо[d]имидазола
EA201590315A1 (ru) Средства и способ лечения солидных опухолей
IN2014MN01495A (ru)
EA201370251A1 (ru) Производное камптотецина, способ получения такового, фармацевтическая композиция и ее применение
WO2014160177A3 (en) Quinazoline inhibitors of pi3k
EA201592167A1 (ru) Способ получения производных пирролидин-2-карбоновой кислоты
MX2015002705A (es) Compuestos de piridinona para usarse en terapia fotodinamica.
MA32342B1 (fr) Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ